Related Experiment Videos
Therapeutic progress--review II. Control of diabetes mellitus
Journal of Clinical and Hospital Pharmacy
|December 1, 1981
Abstract:
Present treatment of diabetes mellitus does not result in cure. Evidence is presented from clinical and animal studies to suggest that metabolic control is important in delaying and sometimes ameliorating long-term complications. New methods of monitoring control and changes in insulin therapy are described, but their effect on chronic diabetic complications cannot be assessed for many years.
Insights
Current diabetes mellitus treatments do not offer a cure. However, evidence suggests that maintaining metabolic control is crucial for delaying and potentially reducing long-term diabetic complications.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetology
Background:
- Current therapeutic strategies for diabetes mellitus lack curative potential.
- Long-term complications of diabetes remain a significant clinical challenge.
- The importance of metabolic control in managing diabetes is increasingly recognized.
Purpose of the Study:
- To review the evidence supporting the role of metabolic control in mitigating diabetic complications.
- To discuss advancements in diabetes monitoring and insulin therapy.
- To highlight the long-term implications of these advancements on chronic diabetic complications.
Main Methods:
- Review of clinical and animal studies.
- Analysis of current monitoring techniques for diabetes control.
- Evaluation of recent changes in insulin therapy protocols.
Main Results:
- Evidence from studies indicates that metabolic control can delay or ameliorate long-term complications.
- New methods for monitoring glycemic control are available.
- Innovations in insulin therapy have been introduced.
Conclusions:
- While not curative, optimizing metabolic control is key to managing diabetes complications.
- The long-term impact of novel monitoring and insulin therapies on chronic complications requires extended observation.
- Further research is needed to fully assess the benefits of new therapeutic approaches.